Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Brief Review of Drug Discovery Research for Human African Trypanosomiasis

23 Feb 2017

Abstract excerpt

Human African Trypanosomiasis (HAT), a neglected disease endemic in Sub- Saharan Africa, is usually fatal if left untreated. It is caused by the parasite Trypanosoma brucei, and is spread by the tsetse fly. The drugs currently available to treat HAT are few, and limited in efficacy. Furthermore, resistance towards these drugs is beginning to grow. In the last 25 years, only one advance has been made into HAT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Research on Leishmaniasis Studies
Share to Trypanosoma species research and implications

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 28117003
DOI: 10.2174/0929867324666170120160034

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 21 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Brief Review of Drug Discovery Research for Human African TrypanosomiasisPMID 28117003Read ↗

The current drug discovery landscape for trypanosomiasis and leishmaniasis: Challenges and strategies to identify drug targetsSemantic proximity Read ↗

Drug discovery for neglected diseases: molecular target-based and phenotypic approaches.Semantic proximity Read ↗

Repurposing of Human Kinase Inhibitors in Neglected Protozoan DiseasesSemantic proximity Read ↗

DRUG DISCOVERY AND DEVELOPMENT FOR NEGLECTED TROPICAL DISEASESSemantic proximity Read ↗

Discovery of a Carbazole-Derived Lead Drug for Human African TrypanosomiasisSemantic proximity Read ↗

Identification of clinically approved small molecules that inhibit growth and promote surface remodeling in the African trypanosomeSemantic proximity Read ↗

Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review)Semantic proximity Read ↗

Of Drugs and Trypanosomatids: New Tools and Knowledge to Reduce Bottlenecks in Drug DiscoverySemantic proximity Read ↗

A Static-Cidal Assay for Trypanosoma brucei to Aid Hit Prioritisation for Progression into Drug Discovery ProgrammesSemantic proximity Read ↗

Finding new hits in neglected disease projects: target or phenotypic based screening?Semantic proximity Read ↗

The critical role of mode of action studies in kinetoplastid drug discoverySemantic proximity Read ↗

Repurposing of the Open Access Malaria Box for Kinetoplastid Diseases Identifies Novel Active Scaffolds against TrypanosomatidsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.